JPRN-UMIN000004662已完成未知
Phase I clinical trial of newly developed antigen peptide vaccine for advanced esophageal cancer - Clinical trial of peptide vaccine for esophageal cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnancy Lactating woman Severe bleeding tendency uncontroled infection concomitant treatment with steroids patients who are judged inappropriate for eligibility by the investigator
研究者
相似试验
进行中（未招募）
1 期
Immunogenicity of anti-pneumococcal vaccination in acute leukemia and lymphomaEUCTR2020-002017-18-FRCHU DE POITIERS160
已完成
不适用
A safety and immunogenicity phase 1 trial with an adjuvated TB subunit vaccine (Ag85B - ESAT-6 + IC31) administered in PPD positive volunteers at 0 and 2 monthsPrevention10028440TuberculosisNL-OMON30684Statens Serum Institut20
已完成
不适用
Phase I clinical trial to assess safety and immunogenicity of an MVA-based influenza H5 vaccine in healthy adultsflu10047438InfluenzaNL-OMON38408Erasmus MC, Universitair Medisch Centrum Rotterdam27
招募中
不适用
Study for development of new treatment for antibody mediated rejection in organ transplantatioorgan failureJPRN-UMIN000030525Tokyo Women's Medical University41
已完成
1 期
Study to evaluate safety and possible adverse reactions, especially serious, with a vaccine for measles and rubella in healthy subjects.Measles and RubellaRBR-9hckj4Bio-Manguinhos/Fiocruz/MS